2023 annual financial data
Tarsus Pharmaceuticals 2023 Operating margin
Direct answer
Operating margin was -820.53%.
Operating income was -143,158,000 USD and net income was -135,893,000 USD.
Operating cash flow was -117,493,000 USD.
Get free Tarsus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,447,000 USD
- Operating income
- -143,158,000 USD
- Net income
- -135,893,000 USD
- Operating cash flow
- -117,493,000 USD